ARTV
Price
$4.00
Change
+$0.01 (+0.25%)
Updated
Feb 13 closing price
Capitalization
98.18M
43 days until earnings call
Intraday BUY SELL Signals
MGX
Price
$1.46
Change
+$0.01 (+0.69%)
Updated
Feb 13 closing price
Capitalization
54.82M
45 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ARTV vs MGX

Header iconARTV vs MGX Comparison
Open Charts ARTV vs MGXBanner chart's image
Artiva Biotherapeutics
Price$4.00
Change+$0.01 (+0.25%)
Volume$39.96K
Capitalization98.18M
Metagenomi Therapeutics
Price$1.46
Change+$0.01 (+0.69%)
Volume$199.27K
Capitalization54.82M
ARTV vs MGX Comparison Chart in %
ARTV
Daily Signal:
Gain/Loss:
MGX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ARTV vs. MGX commentary
Feb 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARTV is a Hold and MGX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 15, 2026
Stock price -- (ARTV: $4.00 vs. MGX: $1.46)
Brand notoriety: ARTV and MGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARTV: 3% vs. MGX: 65%
Market capitalization -- ARTV: $98.18M vs. MGX: $54.82M
ARTV [@Biotechnology] is valued at $98.18M. MGX’s [@Biotechnology] market capitalization is $54.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $124.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARTV’s FA Score shows that 1 FA rating(s) are green whileMGX’s FA Score has 1 green FA rating(s).

  • ARTV’s FA Score: 1 green, 4 red.
  • MGX’s FA Score: 1 green, 4 red.
According to our system of comparison, ARTV is a better buy in the long-term than MGX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARTV’s TA Score shows that 4 TA indicator(s) are bullish while MGX’s TA Score has 3 bullish TA indicator(s).

  • ARTV’s TA Score: 4 bullish, 5 bearish.
  • MGX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ARTV is a better buy in the short-term than MGX.

Price Growth

ARTV (@Biotechnology) experienced а -0.74% price change this week, while MGX (@Biotechnology) price change was -5.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.41%. For the same industry, the average monthly price growth was -4.89%, and the average quarterly price growth was +22.89%.

Reported Earning Dates

ARTV is expected to report earnings on Mar 30, 2026.

MGX is expected to report earnings on Apr 01, 2026.

Industries' Descriptions

@Biotechnology (+2.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARTV($98.2M) has a higher market cap than MGX($54.8M). ARTV YTD gains are higher at: -6.760 vs. MGX (-9.877). ARTV (-83.6M) and MGX (-86.79M) have comparable annual earnings (EBITDA) . MGX has more cash in the bank: 184M vs. ARTV (123M). ARTV has less debt than MGX: ARTV (11.7M) vs MGX (41.7M). MGX has higher revenues than ARTV: MGX (30.9M) vs ARTV (0).
ARTVMGXARTV / MGX
Capitalization98.2M54.8M179%
EBITDA-83.6M-86.79M96%
Gain YTD-6.760-9.87768%
P/E RatioN/AN/A-
Revenue030.9M-
Total Cash123M184M67%
Total Debt11.7M41.7M28%
TECHNICAL ANALYSIS
Technical Analysis
ARTVMGX
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 25 days ago
84%
Declines
ODDS (%)
Bearish Trend 11 days ago
84%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
70%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ARTV
Daily Signal:
Gain/Loss:
MGX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RKUNF6.300.10
+1.61%
Rakuten Group Inc.
THLPF26.82N/A
N/A
Thule Group AB
FIISO124.95N/A
N/A
Financial Institutions, Inc.
VTXXF0.21N/A
N/A
Vertex Minerals Ltd.
ASMMF1.11-0.03
-2.63%
Australian Strategic Materials Ltd.

ARTV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARTV has been closely correlated with QNCX. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if ARTV jumps, then QNCX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARTV
1D Price
Change %
ARTV100%
+0.25%
QNCX - ARTV
94%
Closely correlated
-11.31%
MREO - ARTV
89%
Closely correlated
-4.32%
TPST - ARTV
89%
Closely correlated
+2.16%
CALC - ARTV
89%
Closely correlated
-6.41%
BDRX - ARTV
82%
Closely correlated
-0.92%
More

MGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGX has been loosely correlated with VTGN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if MGX jumps, then VTGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGX
1D Price
Change %
MGX100%
+0.69%
VTGN - MGX
57%
Loosely correlated
-7.23%
CDXS - MGX
57%
Loosely correlated
+1.69%
KRRO - MGX
56%
Loosely correlated
-5.02%
ARCT - MGX
55%
Loosely correlated
+0.56%
ARTV - MGX
55%
Loosely correlated
+0.25%
More